4
Changes in Ownership
DiaMedica Therapeutics Inc. Filed Acc 0001235802-23-000040
Chief Business Officer bought 468,750 shares at $1.60 ($750,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wambeke David J. Chief Business Officer | 2023-04-10 | Purchase | +468,750 | $1.60 | $750,000 | 468,750 | D |
| Derivatives | |||||||
| Wambeke David J. Chief Business Officer | 2023-04-10 | Grant or award · Stock Option (right to buy) | +140,000 | 140,000 | D | ||
| Open-market purchases · 468,750 sh · avg $1.60 · $750,000 | |||||||
Loading xslF345X04/primary_doc.xml…